| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 51 Number 5
Volume 51 Number 4
Volume 51 Number 3
Volume 51S Number 1
Volume 51 Number 2
Volume 51 Number 1
Earlier issues
Volume  Number 

previous article next article

Research articles

ScienceAsia 51S (2025):ID 2025s027 1-6 |doi: 10.2306/scienceasia1513-1874.2025.s027


Comparative analysis of bioactive compounds and anti-inflammatory effects via COX-2 inhibitory activity in forest-derived and tissue-cultured extracts of umbrella moss (Rhodobryum giganteum (Schwägr.) Par.)


Hataichanok Panditha,b,*, Kullanun Mekawana, Pattarasuda Chayapakdeea,b, Witthawin Baiubola, Nipitpawn Limpanicha, Rujipas Yongsawasa, Narin Printarakula,*

 
ABSTRACT:     Rhodobryumgiganteum(umbrellamoss)isatraditionalChinesemedicinalplantprimarilyusedfortreating heart diseases through anti-inflammatory mechanisms. Its key bioactive compounds are 7,8-dihydroxycoumarin and p-hydroxycinnamic acid. Since umbrella moss grows in humid mountain regions, overharvesting wild populations risks extinction and contamination with heavy metals. To address this, tissue culture techniques were developed to propagate the moss sustainably. This study compares the bioactive compounds content and anti-inflammatory efficacy via cyclooxygenase-2 (COX-2) inhibitory activity of forest-derived and tissue-cultured R. giganteum extracts. Both samples were extracted using 60% ethanol and analyzed by high-performance liquid chromatography for active compounds, followedbyenzyme-linkedimmunosorbentassayforCOX-2inhibition. Thetissue-cultured moss hadmuch higher amounts of 7,8-dihydroxycoumarin and p-hydroxycinnamic acid than the natural forest moss. Specifically, it contained about 15 times more 7,8-dihydroxycoumarin (6.16?1.25 ?g/ml vs. 0.41?0.03 ?g/ml) and nearly 5 times more p-hydroxycinnamicacid(17.63?0.47?g/mlvs.3.69?0.06?g/ml). Theseresultsdemonstratethattissueculture not only supports sustainable propagation but also enhances bioactive compound production and therapeutic efficacy. This preliminary in vitro study provides a foundation for developing pharmaceutical products from R. giganteum while conserving natural populations. Further cell-based assays and in vivo studies are necessary to evaluate the therapeutic potential.

Download PDF

Downloads Views


a Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200 Thailand
b Research Center of Deep Technology in Beekeeping and Bee Products for Sustainable Development Goals (SMART BEE SDGs), Chiang Mai University, Chiang Mai 50200 Thailand

* Corresponding author, E-mail: hataichanok.p@cmu.ac.th, narin.printarakul@cmu.ac.th

Received 1 Dec 2024, Accepted 0 0000